Jul 10, 2013 by Brian Orelli, PhDDrug Deal Can Only Help VIVUS So MuchVIVUS signs a good deal with Menarini for its erectile dysfunction drug outside the U.S., but its obesity drug Qsymia is still more important.
Jul 2, 2013 by Brian Orelli, PhDObesity Drug Finally Hits PharmaciesVIVUS' Qsymia is now available at retail pharmacies after FDA approval almost a year ago.
Jul 1, 2013 by Brian Orelli, PhD4 Tempting Health-Care Dividend Stocks to AvoidHigh yields are there for a reason.
Jun 30, 2013 by Brian Orelli, PhDJohnson & Johnson Stock Is Always a Buy (If You Hold Long Enough)Of course, it's still a better buy at some times than others.
Jun 30, 2013 by Brian Orelli, PhD6-Month Checkup on the New Abbott Laboratories Stock Not as sexy as its drug spinoff.
Jun 30, 2013 by Brian Orelli, PhDMerck Stock Depends on Januvia More Than Ever It's going to be an uphill battle to keep sales going.
Jun 28, 2013 by Brian Orelli, PhDBiotech Investing for BeginnersA guide to investing in this industry of the market.
Jun 28, 2013 by Brian Orelli, PhD3 Obamacare-Inspired Investment OpportunitiesLove it or hate it, the new law created investment opportunities.
Jun 27, 2013 by Brian Orelli, PhDWill Pfizer Stock Soar or Sink for the Rest of 2013?With Pfizer slimmed down, new drugs are important to grow the stock price.
Jun 27, 2013 by Brian Orelli, PhD3 Health Care Investment Ideas From Warren BuffettThe famed investor's purchases -- or lack thereof -- say a lot.
Jun 27, 2013 by Brian Orelli, PhDBiotech Companies Battle It OutWho will win these head-to-head competitions?
Jun 26, 2013 by Brian Orelli, PhD3 Winning Biotech Investment Strategies and Their Potential PitfallsThere's no free lunch, but these tips could help you make it big in biotech.
Jun 26, 2013 by Brian Orelli, PhDThe Only True Biotech Dividend StockDividend stocks in the biotech sector are hard to come by.
Jun 26, 2013 by Brian Orelli, PhDInvestment Opportunities in Drug LaunchesPotential for hyper-growth makes these investment opportunities worth a look.
Jun 24, 2013 by Brian Orelli, PhDCheap Viagra That Americans Can't BuyEuropean patents for the erectile dysfunction drug expire, but Americans have to wait until 2019.
Jun 21, 2013 by Brian Orelli, PhDThe Most Unlucky Biotech in the WorldIdenix has another hepatitis C drug put on clinical hold.
Jun 21, 2013 by Brian Orelli, PhD3 Biotech Companies to Watch This SummerStock-moving events are ahead for these biotech companies.
Jun 20, 2013 by Brian Orelli, PhDSomething Fishy? Or Business as Usual?Amarin gets an advisory panel for its fish oil Vascepa.
